These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34375121)

  • 1. Soaring Asymptomatic Infected Individuals Bring About Barriers and Difficulties for Interruption of COVID-19 Prevalence in China.
    Chen M; Ai L; Huang D; Chen J; Feng T; Mei S; Huang Y; Peng B; Zhang S; Zhang R; Zhou X
    Vector Borne Zoonotic Dis; 2021 Oct; 21(10):777-784. PubMed ID: 34375121
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study.
    Zhang S; Guo M; Wu F; Xiong N; Ma Y; Wang Z; Duan L; Chen L; Ouyang H; Jin Y
    Clin Microbiol Infect; 2020 Dec; 26(12):1670-1675. PubMed ID: 32911080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the COVID-19 infection status, prevention and control strategies among people entering Shenzhen.
    Zou X; Xu ZQ; Wang HR; Wang BX; He JF; Wang JZ
    BMC Public Health; 2021 Mar; 21(1):551. PubMed ID: 33743630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
    Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the Proportion of Asymptomatic COVID-19 Cases in an Italian Region with Intermediate Incidence during the First Pandemic Wave: An Observational Retrospective Study.
    Martinelli D; Fortunato F; Mazzilli S; Bisceglia L; Lopalco PL; Prato R
    Biomed Res Int; 2022; 2022():3401566. PubMed ID: 35005026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of global asymptomatic SARS-CoV-2 infection and management practices from China.
    Chen Z; Wang B; Mao S; Ye Q
    Int J Biol Sci; 2021; 17(4):1119-1124. PubMed ID: 33867834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
    Almadhi MA; Abdulrahman A; Sharaf SA; AlSaad D; Stevenson NJ; Atkin SL; AlQahtani MM
    Int J Infect Dis; 2021 Apr; 105():656-661. PubMed ID: 33647516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cluster Transmission of Coronavirus Disease 2019 and the Prevention and Control Measures in the Early Stage of the Epidemic in Xi'an, China, 2020.
    Zhang H; Song S; Chen Z; Bai M; He Z; Fu T; Liu K; Shao Z
    Med Sci Monit; 2021 Jun; 27():e929701. PubMed ID: 34121087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and management of asymptomatic SARS-CoV-2 infections.
    Tanriover MD; Fathi A; Raspe M; Novais AG; Uyaroğlu OA
    J Basic Clin Physiol Pharmacol; 2021 Sep; 33(1):1-7. PubMed ID: 34517438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis.
    Ma Q; Liu J; Liu Q; Kang L; Liu R; Jing W; Wu Y; Liu M
    JAMA Netw Open; 2021 Dec; 4(12):e2137257. PubMed ID: 34905008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological Characteristics of COVID-19 and Effective Public Health Interventions in Shenzhen, China.
    Li G; Lin J; Xu D
    Front Public Health; 2022; 10():923175. PubMed ID: 35844887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China.
    Liu J; Huang J; Xiang D
    Emerg Infect Dis; 2020 Sep; 26(9):2260-3. PubMed ID: 32603652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Asymptomatic Infections in 2 Large Academic Health Systems in Wisconsin.
    Rivera F; Safdar N; Ledeboer N; Schaack G; Chen DJ; Munoz-Price LS
    Clin Infect Dis; 2021 Dec; 73(11):e3974-e3976. PubMed ID: 32812030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological characteristics of COVID-19 in Shenzhen, China: comparison between imported and local cases.
    Li Z; Wang J; Huang J; Lu J
    J Infect Dev Ctries; 2020 Aug; 14(8):853-860. PubMed ID: 32903229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiological characteristics and effectiveness of countermeasures to contain coronavirus disease 2019 in Ningbo City, Zhejiang Province, China.
    Lao X; Luo L; Lei Z; Fang T; Chen Y; Liu Y; Ding K; Zhang D; Wang R; Zhao Z; Rui J; Zhu Y; Xu J; Wang Y; Yang M; Yi B; Chen T
    Sci Rep; 2021 May; 11(1):9545. PubMed ID: 33953243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections.
    Stadler RN; Maurer L; Aguilar-Bultet L; Franzeck F; Ruchti C; Kühl R; Widmer AF; Schindler R; Bingisser R; Rentsch KM; Pargger H; Sutter R; Steiner L; Meier C; Kübler W; Hirsch HH; Egli A; Battegay M; Bassetti S; Tschudin-Sutter S
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):44. PubMed ID: 33640031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.